Stories
As she heads toward retirement at the end of March, Rita Baird looks back on her career at Mayo Clinic Laboratories and discusses her role working with MCL clients as a regional service representative.
This week’s research roundup features a phase III study of lenalidomide plus R-CHOP versus placebo plus R-CHOP in previously untreated patients With ABC-type diffuse large b-cell lymphoma.
Top highlights include: a list of COVID-19 drugs and how they work, policy changes in visitor policy at Mayo Clinic in Rochester, and what to know about kids going back to school.
This week’s research roundup features a study on the sequencing of 53,831 diverse genomes from the NHLBI TOPMed program.
Top highlights include: side effects of the COVID-19 vaccine, tackling the latest pandemic topics, and World Encephalitis Day.
A supervisor in the lab that's at the heart of Mayo Clinic Laboratories' COVID-19 testing, Dave Majewski's job has changed dramatically in the last year, as he went from overseeing about 40 staff members to more than 240 in a lab that now runs 24/7.
This week’s research roundup features a study on trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
This week’s research roundup features an expert review of the AGA clinical practice update on the management of refractory helicobacter pylori infection.
A genetic counselor with Mayo Clinic Laboratories for the last 15 years, Cassie Runke relishes her role serving as a resource for health care providers who are looking to help their patients find answers through genetic testing.
Top highlights include: understanding the effectiveness and safety of the COVID-19 vaccine, COVID-19 terminology, and a patient's experience with a new Mayo Clinic platform.
This week’s research roundup features a study on in Patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity that represent two different phenotypes.
This week’s research roundup features a study on circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.
Top highlights include: maintaining your mental health during challenging times, concerns with COVID-19 variants, and unchecked COVID-19 spread leads to virus variants.